86 studies found for:    MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1
Show Display Options
Rank Status Study
21 Completed Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment
Conditions: Migraine With Aura;   Migraine Without Aura
Intervention: Drug: Sumatriptan+Promethazine (SPr)
22 Active, not recruiting Impact of a Nurse for Migraine Management: the IMPACT Project
Conditions: Migraine Without Aura;   Migraine With Aura;   Chronic Migraine
Intervention:
23 Completed Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for Migraine
Conditions: Migraine With Aura;   Migraine Without Aura
Interventions: Other: Sham chiropractic manipulative therapy;   Other: Chiropractic spinal manipulative therapy
24 Unknown  The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine
Conditions: Migraine Disorders;   Headache, Migraine;   Migraine;   Migraine Headache;   Migraine With Aura;   Migraine Without Aura;   Headache Disorders, Primary
Interventions: Drug: Triptan;   Drug: Doxycycline
25 Completed Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department
Conditions: Probable Migraine;   Migraine With Aura;   Migraine Without Aura
Interventions: Drug: Ketorolac Tromethamine;   Drug: Metoclopramide
26 Completed Candesartan Versus Propranolol for Migraine Prevention
Conditions: Migraine Without Aura;   Migraine With Aura;   Chronic Migraine
Interventions: Drug: Candesartan;   Drug: propranolol;   Drug: placebo
27 Unknown  Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura
Condition: Migraine With Aura
Interventions: Drug: NXN-188;   Drug: Placebo
28 Terminated
Has Results
A Study of a Melatonin Receptor Agonist to Prevent Migraine
Conditions: Migraine;   Migraine With Aura;   Migraine Without Aura
Interventions: Drug: Ramelteon;   Drug: Placebo
29 Completed Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
Conditions: Migraine Without Aura;   Migraine With Aura
Interventions: Drug: Tonabersat;   Drug: Placebo
30 Completed Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache
Conditions: Migraine With Aura;   Migraine Without Aura
Interventions: Drug: Maxalt 10mg MLT plus Caffeine 75mg;   Drug: Maxalt 10mg MLT plus Placebo;   Drug: Placebo + Placebo
31 Completed Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine
Conditions: Migraine With Aura;   Migraine Without Aura
Intervention: Drug: Laxymig ER (drug)
32 Completed Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache
Conditions: Migraine Without Aura;   Migraine With Aura
Interventions: Drug: Tonabersat;   Drug: Placebo
33 Unknown  Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine
Conditions: Migraine;   Migraine Headache;   Migraine Disorders;   Migraine With Aura;   Migraine Without Aura
Interventions: Drug: AST-726 Low dose;   Drug: AST-726 High dose;   Drug: AST-726 Placebo
34 Completed Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache
Conditions: Migraine With Aura;   Migraine Without Aura
Intervention: Drug: Dronabinol MDI
35 Completed Migraine With Aura Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow by Hypoxia
Conditions: Headache;   Migraine;   Aura
Interventions: Other: Hypoxia;   Other: Placebo
36 Completed
Has Results
A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period
Conditions: Migraine With or Without Aura;   Migraine Disorders;   Migraine, Acute;   Migraine Headaches
Interventions: Drug: sumatriptan and naproxen sodium combination tablet;   Drug: sumatriptan tablet;   Drug: naproxen sodium tablet
37 Completed
Has Results
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)
Conditions: Migraine With or Without Aura;   Migraine Disorders;   Migraine
Interventions: Drug: Placebo;   Drug: Combination Product (sumatriptan succinate/naproxen sodium)
38 Completed An Open-labeled Trial of Ramipril in Patients With Migraine
Condition: Migraine With Hypertension
Intervention: Drug: Ramipril
39 Completed Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan
Condition: Migraine With or Without Aura
Interventions: Drug: Placebo;   Drug: Eletriptan 40 mg;   Drug: Eletriptan 80 mg
40 Completed Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo
Condition: Migraine With or Without Aura
Interventions: Drug: Placebo;   Drug: Eletriptan 40 mg;   Drug: Eletriptan 80 mg;   Drug: Sumatriptan 25 mg;   Drug: Sumatriptan 50 mg

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years